Navigation Links
Regeneron Announces February 2012 Investor Conference Presentations
Date:2/21/2012

TARRYTOWN, N.Y., Feb. 21, 2012 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast management presentations at the following investor conferences:

  • Citi 2012 Global Healthcare Conference at 3:00 p.m. Eastern Time on Tuesday, February 28, 2012
  • RBC Capital Markets' Healthcare Conference at 9:00 a.m. Eastern Time on Wednesday, February 29, 2012
  • The sessions may be accessed through the Company's web site, www.regeneron.com, on the Events and Presentations page.  Archived versions of the presentations will be available for thirty days after the live webcasts. 

    Regeneron is a fully integrated biopharmaceutical company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets two products, ARCALYST® (rilonacept) Injection For Subcutaneous Use and EYLEA® (aflibercept) Injection.  Regeneron also has completed several Phase 3 studies and is conducting an additional Phase 3 clinical trial for the product candidate ZALTRAP® (aflibercept) Concentrate for Intravenous Infusion.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on the Regeneron web site at www.regeneron.com.Contact Information:  

     Manisha Narasimhan, Ph.D.

    Peter DworkinInvestor Relations

    Corporate Communications914-847-5126

    914.847.764

    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
    2. Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
    3. Regeneron to Host Conference Call on January 3 at 8:30 a.m. Eastern Time to Discuss Ongoing Patent Litigation
    4. Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
    5. Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review
    6. Rockefeller University President Marc Tessier-Lavigne Elected to Regeneron Board of Directors
    7. Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
    8. Sanofi and Regeneron Report Positive Preliminary Phase 2 Program Results for Anti-PCSK9 Antibody in Hypercholesterolemia
    9. Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
    10. Regeneron Ranked by Science Magazine as the #2 Employer in the Global Biopharmaceutical Industry
    11. Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... , Sep. 03, 2015 ... addition of the "Investigation Report on China Tropisetron ... Tropisetron, developed by Novartis, entered the market in ... the Chinese market in the late 1990s. Tropisetron got ... 1994 after its original developer Sandoz submitted application. But ...
    (Date:9/3/2015)... REHOVOT, Israel, Sept. 3, 2015 OticPharma, Ltd., ... innovative therapies for ear, nose, and throat (ENT) disorders, ... Gateway office complex to be the location of its ... by end of September and will have office locations ... OticPharma, Inc. 19900 MacArthur Blvd., Suite 550 ...
    (Date:9/2/2015)... 2, 2015 About implantable medical devices ... to replace, augment, or repair damaged tissues or ... of applications including cosmetic, spinal, cardiovascular, ophthalmic, and ... different materials such as polymers, metals, ceramics, and ... medical devices market to grow at a CAGR ...
    Breaking Medicine Technology:China Tropisetron (Novartis) Market Report 2015-2019 2OticPharma Establishes U.S. Headquarters in Orange County, California 2Global Implantable Medical Devices Market 2015-2019 2
    ... Water Street Healthcare Partners , a strategic private ... announced today that it has completed a sale and ... CareCentrix is the nation,s leading provider of ... industry.  Water Street sold its majority interest in CareCentrix ...
    ... COPENHAGEN, Denmark and LAGUNA NIGUEL, Calif., Sept. 20, ... today announced that the two companies have entered ... manufacture of bulk IB1001, Inspiration,s intravenous recombinant factor ... of bleeding in individuals with hemophilia B. Under ...
    Cached Medicine Technology:Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix 2Water Street Healthcare Partners Completes Sale and Recapitalization of CareCentrix 3CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001 2CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001 3
    (Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an independent romantic comedy film ... Amazon and will be released on DVD early next year, by Maverick ... Itsuka, an actress and singer/songwriter, and Jason London, lead from “Dazed and Confused.” ...
    (Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have ... of two categories: those that have a weak appetite or those that have a fast ... to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The ...
    (Date:9/3/2015)... ... 03, 2015 , ... Doctor Kayode Sotonwa can be counted on ... perspective on internal medicine keeps patients happy and healthy, something that is important to ... the season, but even more so in the fall, when holiday eating and seasonal ...
    (Date:9/2/2015)... (PRWEB) , ... September 03, 2015 , ... One can ... with higher frequency than they do laptops and personal computers. These devices are being ... the evolution and the revolution of mobile dating apps, STD positive singles can now ...
    (Date:9/2/2015)... ... September 02, 2015 , ... ... Symposium (WFS), cosponsored by the Military Officers Association of America (MOAA) and ... "Our Nation's Military: Caring For Our Own,” expert panelists will lead interactive ...
    Breaking Medicine News(10 mins):Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3
    ... March 25 KV Pharmaceutical Company,(NYSE: KVA/KVB), ... manufactures, acquires and markets technology differentiated,branded and ... its fiscal 2007 Form 10-K with the ... restatements of previously reported results for,fiscal years ...
    ... In a ceremony,attended by Ohio,s physician leaders, ... of the most sweeping physician-insurance industry,contract reform bills ... law, which will take effect in ninety days, ... the contracting process,fairness in contracting, and a standardized ...
    ... Evalve, Inc., the leader,in the development of devices ... Mark approval for its MitraClip(R) system. The,MitraClip is the ... patients suffering from the effects of mitral,regurgitation (MR)., ... insufficiency in the United,States and the second most common ...
    ... Inc. (Nasdaq: MAPP ) today announced the ... board of directors. Mr. Wolff,brings over 25 years ... will,also serve on the audit committee., Mr. ... Financial,Officer at Richmond, Calif.-based Sangamo BioSciences, Inc. where ...
    ... recurrence and new malignancies surfaced , , TUESDAY, March 25 ... concerning women and hormone replacement therapy: Not only do ... while taking the therapy, breast cancer survivors who do ... or a new malignancy. , "This is the first ...
    ... has been,appointed as the Richard Merkin Distinguished Professor ... Richard Merkin, President of,Heritage Provider Network and avid ... of his endowment because of his passion for ... increasingly dependant on,mathematics. Math is the fabric with ...
    Cached Medicine News:Health News:KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K 2Health News:KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K 3Health News:KV Pharmaceutical Company Completes Financial Restatement with the Filing of Fiscal 2007 Form 10-K 4Health News:Governor Strickland Signs House Bill 125 Into Law 2Health News:Correction: Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 2Health News:Correction: Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 3Health News:Correction: Evalve Announces CE Mark Approval of the World's First Percutaneous Valve Repair System 4Health News:MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors 2Health News:HRT Raises Recurrence Risk Among Breast Cancer Survivors 2Health News:Danny Calegari Appointed the Richard Merkin Distinguished Professor of Mathematics at the California Institute of Technology 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: